SOURCE: Healthmed Services

Healthmed Services

October 04, 2010 16:00 ET

Healthmed's Neuro Vantage Targets Commercial Market

SUNNYVALE, CA--(Marketwire - October 4, 2010) -  Healthmed Services, Ltd. (OTCQB: HEME) (PINKSHEETS: HEME), an innovative software and application development company, confirms the Company is testing the neural communicator on a voluntary select group of individuals. Healthmed's extraordinary research and development team, winners of Microsoft's 2010 Imagine Cup, is testing Neuro Vantage in military medical establishments. The Company hopes to create a new level of mobility to troops with disabilities. 

Disabled individuals suffering from paralysis, amputation, or spinal cord injuries will now be able to communicate easier with Neuro Vantage. The application uses biotechnological equipment that receives subdued neural signals which command the functions of the computers and mobile equipment.

While the healthcare industry will remain the main focus, it has been established the communicator will present excellent opportunities for industrial, military and gaming commercialization purposes.

Please read more about the Company and its product developments on its website:

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed with the Securities and Exchange Commission.

Contact Information